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Enzymes are an integral part of biological systems. They constitute a signiﬁcant majority of all
proteins expressed an estimated 18%–29% within eukaryotic genomes. It thus comes as no major
surprise that enzymes have been implicated in many diseases and form the second largest group of
drug targets, after receptors. Despite their involvement in a multitude of physiological processes,
only a limited number of enzymes have thus far been well-characterized. Consequently, little is
understood about the physiological roles, substrate speciﬁcity, and downstream targets of the vast
majority of these important proteins. In order to facilitate the biological characterization of enzymes,
as well as their adoption as drug targets, there is a need for global “-omics” solutions that bridge the
gap in understanding these proteins and their interactions. Herein the authors showcase how
microarray methods can be adopted to facilitate investigations into enzymes and their properties, in
a high-throughput manner. They will focus on several major classes of enzymes, including kinases,
phosphatases, and proteases. As a result of research efforts over the last decade, these groups of
enzymes have become readily amenable to microarray-based proﬁling methods. The authors will
also describe the speciﬁc design considerations that are required to develop the appropriate chemical
tools and libraries to characterize each enzyme class. These include peptide substrates,
activity-based probes, and chemical compound libraries, which may be rapidly assembled using
efﬁcient combinatorial synthesis or “click chemistry” strategies. Taken together, microarrays offer a
powerful means to study, proﬁle, and also discover potent small molecules with which to modulate
enzyme activity. © 2010 American Vacuum Society. DOI: 10.1116/1.3462969
I. INTRODUCTION
Speed and throughput are key drivers for “-omics” re-
search. Differing from traditional hypothesis driven-research
in biology, “-omic” methods are largely discovery-driven and
seek to adopt a comprehensive view of the overall system.1,2
By leveraging on throughput and comparative proﬁling, this
research method generates a wide information base about a
particular biological state, within a short space of time.3 The
data generated fuels the next wave of more speciﬁc research
questions. This adoption of -omic methods has successfully
catalyzed discovery and knowledge growth in biology since
the 1990s and continues to spur on biomedical and life-
science research in the 21st century.4 Miniaturization and
automation further underpin the ability of many -omic plat-
forms to deliver the intended throughput.
The microarray is a platform that delivers phenomenal
screening throughput and capabilities.5–8 The concept at the
heart of the technology is elegant, yet simple: by presenting
large collections of molecules at a high density on a ﬂat
surface, one is able to interrogate them quickly and conve-
niently, evaluating all possible interactions in a single step.
Protein, peptide, and small molecule microarrays have over
the last decade been established as a robust tools for screen-
ing, lead discovery, and molecular characterization. The
identity of each spot is encoded by its position on the array.
Anywhere from the hundreds to tens of thousands of samples
may be populated on planar surfaces, typically glass or gold-
coated slides.9 The spectrum of applications is determined by
the nature and class of molecules immobilized.
DNA microarrays, for instance, were developed in the
early-mid-1990s by the groups of Maskos and Brown, and
comprised surfaces with addressed oligonucleotides.10–13
Each spot on the array displays a known DNA sequence.
Thousands of them collectively on the microarray act like
“probes” to, quantitatively or comparatively, hybridize ﬂuo-
rescently labeled DNA from complex samples. This offers
tremendous potential for applications in proﬁling the expres-
sion levels of mRNA and in identifying chromosomal abnor-
malities, other genetic differences across samples.14,15 DNA
microarrays continue to be widely applied and provide an
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unprecedented view into comparative genomics and
genetics.16 They were the ﬁrst in a long pipeline of a variety
of different microarray types.
As the chemistries improved, a variety of molecules other
than DNA, including proteins,9,17–19 peptides,6,20,21
carbohydrates,22–24 and chemical libraries2,25 were likewise
arrayed and presented on microarrays. This happened at the
turn of the century, when Schreiber et al. developed microar-
rays containing small molecules in 1999 and proteins in
2000.26,27 With these exciting developments, it did not take
long before proteome arrays,28,29 cell arrays,30–32 and tissue
arrays33 also emerged, all within the ﬁrst quarter of the last
decade. The essence of what makes microarray technology
so successful is its ability to miniaturize and parallelize
assays.2,34
Microarrays for enzyme proﬁling, the topic of this review,
describes both synthetic and natural libraries of peptides, car-
bohydrates, and chemical compound libraries. Simply put,
the application of these microarrays is biological screening,
but covers specialized applications in protein ﬁngerprinting,
ligand discovery, and enzyme-substrate characterization. Be-
ing able to assess these interactions in high-throughput thus
offers valuable potential for enzyme characterization and
drug discovery, discriminates enzymes by their patterns of
interactions, and provides insight into molecular interactions
and structure-activity relationships.35,36 Furthermore, if many
substrates are arrayed, it provides a window into identifying
the most preferred substrate for any given enzyme.20,37,38
These experiments are maturing to a point that they are not
just being carried out with puriﬁed targets, but even with
enzymes within whole proteomes or cellular lysates,39–41 in
order to interrogate protein-protein interactions and analyze
the pathways involved in regulating protein function.42–45
Enzymes are an integral part of every cellular process and
metabolic exchange. They are proteins that not only sustain
life but are also implicit to its regulation and evolution. Mi-
nor changes in enzyme activities, either through point muta-
tions or expression changes, are known to cause major dis-
eases such as cancer, arthritis, Alzheimer disease and even
promote tumor metastasis.46 Similarly pathogens including
many types of viruses and bacteria may be targeted by ex-
ploiting the uniqueness of their enzymes and metabolic
processes.14,47
There is hence a pressing need to elucidate the subtle
differences that make each enzyme unique. A detailed under-
standing of the architecture of enzyme active sites facilitates
not only the design of potent and selective inhibitors but also
the discovery of its biological function and downstream
targets.48 The challenge is in developing cost-efﬁcient and
high-throughput means to perform screening and enzyme
proﬁling. Several key components in microarray research
and development, mainly library creation, array fabrication,
and the instrumentation, have in the past been prohibitively
expensive. However, the increased maturity of the platform,
the reducing cost and accessibility to compound libraries and
the instruments at core facilities, is making it a more cost-
effective and viable option for routine screening.5,49 Microar-
ray fabrication services are also now being provided as a
fee-for-service option by commercial vendors, allowing re-
searchers to focus on the downstream application of the
technology.49
The design of microarray approaches is heavily inﬂu-
enced by the class of enzymes being tested and their associ-
ated catalytic function. Kinases, for example, transfer a phos-
phate group onto a hydroxyl-containing side chain namely,
that of serine, threonine, or tyrosine within a cognate amino
acid sequence of a protein substrate. Phosphatases reverse
this process by removing the phosphate group. The interplay
between these two groups of enzymes gives rise to the dy-
namic signal transduction pathways in eukaryotic systems
used for inter- and intracellular communications. Proteases
on the other hand hydrolyze the peptide bond linking amino
acids in proteins. These serve several functions, including
protein trafﬁcking and export, as well as in cell-cell signaling
and protein degradation. There are over 518 kinases in the
human kinome,50 1036 proteases in the degradome,51 and
180 phosphatases in the phosphatome.52 Before the develop-
ment of high-throughput tools, it was a signiﬁcant challenge
to study the intricacies among these, as well as the many
other classes of enzymes.
This article will describe the design and application of
microarray approaches for studying kinases, phosphatases,
and proteases, and examine the unique solutions for each
class. Section II will include discussions on the chemistries
that have made it possible to rapidly synthesize and assemble
large assortments of compounds. We will then highlight in
Sec. III the technologies that have been developed to accel-
erate the biochemical screening of various classes of en-
zymes. Finally we will discuss some of the important bio-
logical ﬁndings, as well as the future directions of this
rapidly maturing ﬁeld.
II. LIBRARY DESIGN AND FABRICATION
Library design and creation is the ﬁrst and perhaps the
most critical step in any microarray project. For most appli-
cations, the libraries involved are either those of the enzymes
themselves which are then expressed and proﬁled using
high-throughput cloning/protein expression and puriﬁcation
strategies or those of the substrates and/or inhibitors. Sub-
strates and inhibitors are usually fabricated by chemical
means and will be elaborated upon in this section. This in-
clude libraries of peptides in the case of kinase and protease
substrates, phosphopeptides in the case of phosphatase sub-
strates, and small molecule peptide mimics when the intent
is to screen enzyme inhibitors. Depending on the enzyme
class, speciﬁc cognate libraries and sequences are designed,
with speciﬁc sites along the substrate diversiﬁed with natu-
ral, or even unnatural, amino acids. The main consideration
in designing such a library is balancing its cost against the
desired diversity space for enzyme screening and proﬁling. It
almost goes without saying, the larger the library, the greater
the cost in terms of manpower, time and resources required.
This has to be weighed against the investment into the li-
brary size and diversity, which could lead to a greater likeli-
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hood of meaningful results to discriminate and proﬁle the
enzymes of interest. Ideally the chemistries used should be
efﬁcient and high yielding, to avoid the need for library pu-
riﬁcation and yet be at sufﬁciently high quality for a mean-
ingful ﬁrst-tier screen.
A. Microarray fabrication approaches
There are in general three fabrication approaches, of rel-
evance to enzyme proﬁling on microarrays. First, in situ cre-
ation allows microarrays to be built, usually by iterative cou-
plings of the building blocks, to create the entire library on
the slides themselves Fig. 1a. This is similar to methods
developed for SPOT-synthesis, where peptide arrays are built
by iteratively coupling amino acid building blocks onto
membranes.53 This was originally demonstrated on glass
slides for short peptides through the use of photolithography
with photomasks, a method still in use today for the com-
mercial fabrication of high-density DNA microarrays.54 To
reduce the expenses involved as photomasks are costly,
Gulari et al. simpliﬁed the process through the use of photo-
generated acids that could be activated using precise light-
control to facilitate parallel in-situ peptide synthesis.55 This
method, however, involved many coupling steps because of
the 20 amino acids that have to iteratively coupled on the
arrays. A recent development to minimize some of these
challenges was developed by Breitling et al. using electri-
cally charged solid amino acid particles to efﬁciently couple
the synthesis of all 20 different amino acids in a single step,
reducing the cycles needed for array fabrication.21,56,57 In situ
methods offer limited opportunities for quality checks or the
removal of truncated products; hence the chemistries adopted
have to be very efﬁcient to ensure high quality arrays.
Second is the fabrication of libraries, usually with the
inclusion of a tag, and the subsequent deposition on the mi-
croarray surface using piezoelectric methods or contact print-
ing Fig. 1b. This is the most common method for mi-
croarray fabrication, so it will be discussed at some length
here. It is greatly preferred that each library member is
known and identiﬁed a priori, before the arraying process.
This, however, imposes a considerable burden to the synthe-
sis phase, as it comes at the expense of added time, effort,
and cost. To cater for this, methods have to be built in to
ensure that every library member can be identiﬁed at the end
of the combinatorial synthesis process. Because of the chal-
lenges involved, certain groups have sought to use mass
spectrometry to deconvolute identiﬁed hits only after sample
application.58,59 The adoption of tea-bag style synthesis, us-
ing radiofrequency tags, has, however, made it possible to
synthesize large chemical libraries, with each member iden-
tiﬁable at the end of the synthesis process.60
The synthesis process should also at some point include a
tag to enable covalent immobilization on the arrays.34 If the
tag is generic like a common amine or carboxylic acid or
aldehyde and appears at multiple locations of the molecules,
it results in regiospeciﬁc immobilization. In this context, any
of the tags present within the molecule could bind to the
functionalized microarray surface, hence presenting the mol-
ecules in one of several possible orientations. This results in
a mixed orientation of molecules within a spot. The pH of
the immobilization buffer used can, for example, favor im-
mobilization of terminal amines in place of epsilon amines of
lysines because of their different acid dissociation constants
pKa.
Site-speciﬁc immobilization involves a unique tag present
at one predeﬁned position in the library. This tag chemose-
lectively binds the functionalized array surface. For most ap-
plications, site-speciﬁc immobilization is preferred as the
molecules are homogenously presented on the array surface.
Where the binding epitopes are unknown, or where one
would like to present more facets of the molecules for inter-
action, regiospeciﬁc immobilization may be preferred to not
constrain the molecules to any predeﬁned orientation.61–63
Certain tags may also be applied that facilitate noncovalent,
but nevertheless stable immobilization of molecules onto the
surface. These include the use of polyhistidine tag with a
nickel or NTA surface, the biotin tag with an avidin sur-
face, and epitope tag like ﬂag or glutathione-S-transferase,
GST for immobilization on antibody coated surfaces.64,65
The third method of interest for array creation is the use
of DNA or PNA-tags for deconvolution Fig. 3a. These
methods adopt the use of DNA microarrays for hit deconvo-
lution and apply peptide nucleic acids or other oligonucle-
otides that have also been used as tags for small molecule
libraries. The positive hits are identiﬁed through hybridiza-
tion onto DNA microarrays. These strategies have been ap-
plied to proﬁle the substrates of a variety of serine and cys-
teine proteases.66–68 Separately, this has also been creatively
applied to study the binding of proteins to multivalent
ligands and inhibitors, through directed self-assembly of the
probes.69,70
B. Chemical synthesis strategies
For most of the methods described herein, combinatorial
chemistry has been the key driver catering to the provision of
large libraries of compounds. The use of solid supports, split-
pool synthesis, and encoding techniques tea bag synthesis
have facilitated the synthesis of vast libraries of compounds,
FIG. 1. Color online Peptide and small molecule microarray fabrication
methods. a Iterative coupling for in situ library synthesis. b Site-speciﬁc
immobilization of tagged combinatorial libraries, printed on slides using
microarray spotters.
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including peptides, druglike molecules, and
carbohydrates.71,72 Schreiber et al. developed and pioneered
various approaches of combinatorial library design and syn-
thesis for microarray fabrication.26,59 This has included di-
versity oriented synthesis to generate structurally unbiased
libraries as well as one bead-one stock solution split-pool
approaches.73 Synthesis on solid support provides a variety
of advantages over solution-phase synthesis. Through auto-
mation, repeated coupling cycles can be easily carried out,
and the use of such solid supports allows reactions to be
driven to completion by using high concentrations of reac-
tants, ensuring high-yields and purities for standard, well-
optimized chemistries. Reactions that give low yields are,
however, not amenable to synthesis on solid support, as it-
erations on solid support will diminish overall yield and pu-
rity. Synthetic strategies on solid support include position
scanning libraries, alanine-scanning libraries, diversity-
oriented synthesis, and other approaches.74
Other methods for library fabrication include newer frag-
ment based approaches that enable the assembly of large
libraries of diverse molecules totaling N1N2 from smaller
numbers of building blocks totaling N1+N2, where N is the
number of each type of building blocks. This is of particular
interest for targeted library synthesis where different inhibi-
tor building blocks may be combinatorially assembled to
maximize the diversity space available for screening. “Click
chemistry,” a term coined by Sharpless et al., is one such
fragment-based tool that has received a considerable amount
of attention in recent years because of its ease of use and
high-efﬁciency.75 One of the best known types of “click”
reactions is the CuI catalyzed 1,3-dipolar cycloaddition re-
action between azides and terminal alkynes.76,77 Other click
reactions include the Staudinger ligation which has also been
applied in array fabrication.78,79
We have found it very convenient to apply highly strate-
gies such as “click chemistry” and amide-forming
reactions.80 Here the different building blocks of enzyme
substrates, inhibitors or activity-based probes, may be con-
veniently assembled together at the ﬁnal stages of the syn-
thetic process, in contrast to bottom up synthesis. Such a
modular design and synthesis greatly expands the catalomic
toolbox by enhancing the speed and efﬁciency of library fab-
rication. Similar library sets may be designed with different
handles for activity-based probes in one study and also be
used to generate combinatorial libraries of substrates or in-
hibitors in another, hence avoiding duplication of the syn-
thetic effort. Click reactions are mild and highly efﬁcient,
often providing quantitative yields. This facilitates “one-pot”
style synthesis and screening, where the reaction products
may be synthesized and used directly in situ, for biochemical
and microarray-based screening.
In the early years, the investment in expensive equipment
and reactors for combinatorial synthesis was one barrier lim-
iting access to microarray technology. Over the last decade,
improved chemistries for synthesis and immobilization,
coupled with commercial support, now brings about greater
access to robust library and microarray fabrication. Prefabri-
cated arrays and coated microarrays slides, and even mi-
croarray vendors who now offer complete design and array
fabrication packages, will make the platform more accessible
to interested users.49
III. MICROARRAY-BASED SCREENING AND
APPLICATION
The landmark papers by Schreiber and Snyder in 2000
and 2001 established that proteins can retain their activity
even when physically immobilized on microarrays.27,29 This
broke a long standing paradigm that macromolecular pro-
teins with complicated and delicate structures would be de-
natured when immobilized on solid surfaces. Many groups
have since shown that enzymes, even covalently immobi-
lized on such array substrates, still retain their activities and
can be thus studied in parallel. Of course, a great deal of care
needs to be taken when working with enzymes under these
conditions. Certain enzymes may also be very delicate and
could quickly lose activity once immobilized on arrays. The
use of linkers and three-dimensional arrays hydrogels have
also aided in preserving the activity of proteins on
microarrays.81,82
A. Substrate proﬁling
Early work by Ellman et al. showcased ways in which
peptide microarrays may be applied to proﬁle proteases Fig.
2a.83 By taking advantage of ﬂuorogenic peptide sub-
strates anchored on microarrays, the study was able to test
FIG. 2. Color online Proﬁling enzymes using substrate microarrays. a
Fluorogenic peptide microarrays for protease proﬁling. b Kinases are
screened against peptide substrate microarrays that contain the relevant
amino acid residue e.g., Ser, Thr, or Tyr. c Phosphatases may be screened
against phosphopeptide arrays. In this case, the reduction of signal is indica-
tive of the preferred substrate.
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for the activities of several proteases, including trypsin,
granzyme B, and thrombin. The coumarin-based derivatives
facilitated the proﬁling of nonprime N-terminal segment of
the substrate recognition motif to be explored, through moni-
toring the cleavage of the anilide bond that liberated strong
coumarin ﬂuorescence. Our group also reported a broader
application of coumarin derivatives on microarrays to study
proteases as well as esterases, phosphatases, and other hy-
drolases on microarrays.84 Besides hydrolases, Park and Shin
developed microarray methods to assess the activities of
glycosyltransferases.85 Oh et al. demonstrated the analysis of
sumoylation SUMO-small molecule ubiquitin modiﬁer us-
ing microarrays.86
Diamond et al. were the ﬁrst to develop a droplet-based
method using microarrays to assay the substrate speciﬁcity
of serine and cysteine proteases in which ﬂuorogenic sub-
strates and enzymes are sprayed in aerosol form onto the
slides.37,38 A 722-member coumarin peptide library was de-
posited in glycerol droplets on the microarrays, thereafter the
proteases were delivered to the arrays in an aerosolized
spray. The platform was applied to characterize the substrate
spectrum of rhodesein, a papainlike cysteine protease from
the parasite, Trypanosomes brucei.37 It was also used to dis-
tinguish the substrate preferences of thrombin obtained from
various sources. A 361-member subset of the peptide library
was also applied to characterize proteolytic activity of hu-
man plasma.87 Alternative surfaces have further been devel-
oped for droplet-based enzyme proﬁling.88–90 Using slides
coated with ﬂuorogenic substrates, activity-dependent pro-
ﬁles of proteases and phosphates may obtained in nanoliter
sized droplets, in a time- and concentration-dependent
manner.
90 This method was applied to screen for inhibitors of
metalloproteases, namely, thermolysin and collagenase, us-
ing nearly 150-fold less substrate in comparison to the tradi-
tional microplate method.20 A similar droplet-based method
has been developed using sequential piezoelectric deposition
with larger droplet sizes 100–150 nl.91
Apart from hydrolases, methods have also been developed
to screen the substrate speciﬁcity of kinases using peptide
microarrays Fig. 2b. The use of ﬂuorescently labeled an-
tiphosphoserine and antiphosphotyrosine antibodies, or phos-
phospeciﬁc dyes has overcome the traditional need for radio-
active methods to detect kinase activity.92–94 We studied the
use of combinatorial peptide libraries to obtain the activities
of a kinase p60-Src, demonstrating the possibility of using
such peptide libraries to screen for kinase substrate
speciﬁcity.95 This was signiﬁcant as it demonstrated that
apart from conventional one-spot one-compound style ap-
proaches, one-spot many-compound approaches could also
be used for informative screening on peptide microarrays. An
alternative was the use of a phosphospeciﬁc dye, Pro-Q Dia-
mond, for the highly sensitive measurement of peptide phos-
phorylation on microarrays.96
Various groups have pursued large scale kinase screening
initiatives, not only to understand the target spectrum of ki-
nases but also to uncover their underlying roles in signal
transduction pathways under diverse physiological states. By
leveraging on methods by which the phosphorylated peptide
motifs could be distinguished from the unphosphorylated
peptides, kinases could readily be proﬁled using peptide mi-
croarrays. Expanding on the scale and content, Schutkowski
et al. built a large scale microarray for kinase screening
which included 6912 peptides on a single chip.97,98 An
N-terminal aminoacetyl tag was used to facilitate covalent
attachment to aldehyde slides. The library comprised 710
human phosphorylation sites incorporated as 13-mer peptide
sequences. The microarrays were screened against protein
kinase A PKA, casein kinase 2 CK2, and
3-phosphoinositide-dependent protein kinase PDK1 to suc-
cessfully reveal preferred target sequences/motifs. The same
group also reported the use of 13 000 peptides across six
microarray slides to proﬁle casein kinase 2 CK2 and Abl
kinase.99,100
Wang et al. studied the transmembrane KPI-2 kinase, a
member of the human lemur kinase family, using a 1154
member peptide microarray.101 They uncovered that despite
its putative classiﬁcation as a Tyr kinase by sequence ho-
mology, KPI-2 speciﬁcally phosphorylated only Ser/Thr
containing peptides on the microarray. The best substrate
corresponded to Ser-737 in the regulatory domain of the cys-
tic ﬁbrosis transmembrane conductance regulator. Brock et
al. adopted a unique approach for exploring signal transduc-
tion on microarrays. By applying cell lysates under differen-
tial states, they developed a model system to investigate
T-cell signaling.102 In another application that utilized cellu-
lar lysates, Katayama et al. demonstrated the ability to moni-
tor the activities of both PKA and PKC simultaneously.40
Phosphopeptide libraries have also been fabricated and
immobilized on microarrays to test the activities of phos-
phatases, in assaying their ability to remove the phosphate
group from speciﬁc amino acid sequences Fig. 2c.103,104
These strategies have enabled the screening of serine and
threonine phosphatases PP2A, Lambda, PP1 using microar-
rays. A phosphospeciﬁc dye Pro-Q Diamond was used to
detect the signal decrease from the phosphopeptide library as
a result of dephosphorylation by phosphatases. Distinct
phosphatase proﬁles were obtained using a panel of 89 dif-
ferent phosphopeptides, which were immobilized using a bi-
otin tag onto streptavidin coated slides. Unique proﬁles were
further obtained upon coincubation of a phosphatase, PP2A
with a potentially regulatory peptidyl-prolyl isomerase Pin1,
demonstrating that this strategy is applicable in studying the
regulatory role of different proteins within the signal trans-
duction cascade. This led to the discovery that the dephos-
phorylation of a protein involved in apoptosis Bcl-2 is
regulated by both Pin1 and PP2A.103 Waldmann et al. ap-
plied Staudinger ligation to chemoselectively ligate 48 phos-
phorylated peptides onto phosphane glass surfaces. The ar-
rays were screened with protein tyrosine phosphatases
PTP1B and PTP and probed with a ﬂuorescently tagged
antiphosphotyrosine antibody, to assess signal reduction as a
result of phosphatase activity.104
We recently developed a “substrate trapping” peptide mi-
croarray which facilitated the substrate screening of putative
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protein tyrosine phosphatases PTPs, and determination of
the potent and speciﬁc binders of different PTPs.105 This was
achieved by replacing the conserved active site cysteine resi-
due with serine, to generate a substrate-trapping mutant that
retains the substrate recognition property but loses its de-
phosphorylation ability. As a result, the enzyme is linked
with its substrate of choice. Using dual-channel dye labels,
we intercompared the substrate binding proﬁles of phos-
phatase mutants and were able to discern very subtle differ-
ences in the substrate binding of two closely related phos-
phatases i.e., PTP1B and TCPTP. A putative peptide
sequence derived from mitogen kinase was found to prefer-
entially bind PTP1B over TCPTP. This may have potential
therapeutic implications.
B. Inhibitor proﬁling and protein ﬁngerprinting
Mihara et al. were among the earliest to develop protein
ﬁngerprinting approaches using immobilized peptides on
microarrays.106,107 A 112-member -helical peptide microar-
ray was used to distinguish seven proteins. In another ex-
ample, Kodadek and Reddy developed high-density microar-
rays comprising 7680 octameric peptoids, which were
applied in the large-scale protein ﬁngerprinting of three
model proteins.108 In this case, the library was designed in a
manner in which the identities of the library members remain
unidentiﬁed, preventing functional binding data to be eluci-
dated from the protein binding proﬁles. Microarrays have
similarly been applied for inhibitor identiﬁcation, particu-
larly for caspases,109 cysteine proteases,110 and
metalloproteases.20
Through the use of activity-based-probes, protein arrays
may be screened and tested for enzyme activity and inhibi-
tion Fig. 3b.111 We ﬁrst demonstrated the method using a
series of enzymes immobilized on epoxy slides, including
serine proteases, cysteine proteases, and phosphatases.112
These enzymes were screened against activity-based-probes,
which covalently bound only active proteins. The probes car-
ried a ﬂuorescent reporter tag, to enable visualization of the
active enzyme spots within the microarray. Schmidinger et
al. demonstrated a similar strategy against lipolytic
enzymes.113 Taking the strategy further, Miyake et al. were
able to study quantitative inhibitor kinetics by adding various
concentrations of inhibitors to the probe mixture and moni-
toring the probe labeling efﬁcacy in a time-dependent man-
ner on the microarrays. This enabled the on-chip determina-
tion of inhibition constants.114,115
Koehler et al. developed a library of compounds that re-
sembled suberoylaniline hydroxamic acid SAHA.116 This is
a compound that inhibits members of the histone deacetylase
HDAC family of enzymes. Conjugated using ﬂuorous tags,
a library of 20 SAHA-like compounds were immobilized on
ﬂuorinated slides. HDACs catalyze the hydrolysis of
N-acetyl groups on lysine residues found in the N-terminal
tails of histone proteins. Binding proﬁles generated using the
small molecule microarrays enabled the identiﬁcation of se-
lective inhibitors against different HDAC homologs. It was
also demonstrated that HDACs present in cell lysates could
be proﬁled and detected on the microarrays using ﬂuores-
cently labeled antibodies.
Building on these approaches, we found that the false
positive rate on microarrays could be signiﬁcantly alleviated
by applying a two-color protein application where the same
protein is labeled in two channels, one channel is left un-
treated while the other is heat denatured; both channels are
applied simultaneously on the arrays. Spots in the denatured
channel that came up bright usually indicated false positive
interactions that we reasoned were most likely not associated
with the functional activity of the protein Fig. 3c. Sub-
tracting these signals away from the active channel provides
a data set that is more representative of the actual functional
proﬁle of enzymes. We applied this approach to compara-
tively proﬁle four metalloproteases namely, thermolysin,
carboxypeptidase A, collagenase, and anthrax lethal factor.
The microarrays comprised 1400 hydroxamate peptides hy-
droxamate was chosen as the zinc binding group, to target
the enzyme active site that were permuted across the prime
positions and site-speciﬁcally immobilized on avidin-coated
surfaces.117 Concentration dependent protein application fur-
ther enabled KD data to be obtained for hundreds of inhibi-
tors simultaneously on the microarrays. The identity of each
of the inhibitors was known a priori unlike the earlier syn-
thetic approach by Kodadek et al.108. This enabled preferred
peptide ligands to be identiﬁed for each of the proteins ﬁn-
FIG. 3. Color online Microarray-based enzyme ﬁngerprinting and inhibitor
discovery. a The application of PNA/DNA tagged libraries and DNA mi-
croarrays for hit deconvolution. b Use of activity-based probes for enzyme
annotation and inhibition proﬁling. c Inhibitor discovery and enzyme ﬁn-
gerprinting using small molecule microarrays.
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gerprinted, directly from the high-throughput screening re-
sults.
Taking the two-color strategy one step further, we inter-
compared closely related proteins using microarrays. Across
slide comparisons can be a great challenge because of slide-
to-slide variations; hence comparing two proteins on the
same slide allows actual functional differences to be more
readily elucidated. A 1000-member fragment-based
phosphoserine/threonine heptapeptide library was generated
to screen the activity of the family of seven human 14-3-3
proteins on microarrays, which are important cellular regu-
lators that bind to phosphoserine-containing proteins.118 14-
3-3 proteins are very closely related, and it has been a chal-
lenge to identify their unique target speciﬁcities. The
microarray-based two-color screening method revealed a
novel target sequence that bound 14-3-3 Sigma, which is a
protein implicated in tumorigenesis.118
In another interesting development, Dordick et al. devel-
oped cytochrome P450 CYP arrays that are able to screen
for enzyme activity and inhibition. In one demonstration,
sol-gel encapsulated P450 enzymes on microarrays were
used to activate a prodrug, cyclophosphamide. These mi-
croarrays were then stamped with a MCF7 cell monolayer a
breast cancer cell line against which the drugs showed cy-
totoxicity, if these molecules were appropriately converted
by the relevant CYP isoforms.119 More recently, coupled
with high-throughput array imagers, the group has developed
ﬂuorescent assays to study the activity of encapsulated CYP
enzymes on microarrays.120
IV. CONCLUSION
In conclusion, we have herein showcased how microarray
methods can be adopted to facilitate investigations into en-
zymes and their properties, in a high-throughput manner. Us-
ing examples of different enzymes, particularly kinases,
phosphatases, and proteases, we have described experimental
designs and microarray construction to characterize each en-
zyme class. As a result of research efforts over the last de-
cade, these groups of enzymes have become readily ame-
nable to microarray-based proﬁling methods. It has become
routinely possible to implement high-throughput screening
assays for these as well as many other classes of enzymes.
This is already contributing to the large-scale assimilation
and integration of data, to provide for a future where simu-
lation and prediction of biological effects of molecular inter-
action in silico may be completely possible. With the great
progress made over the last decade, the ﬁeld of microarray-
based enzyme proﬁling continues to expand at a remarkable
pace.
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